CLABD (CLABD) Stock Price, News & Analysis

Name: CLABD (CLABD) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

CLABD OTC Pink

Company Description

This page collects what Stock Titan holds for CLABD, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

January 21, 2022

—

Core One Labs Announces Successful Proof of Concept and Files Patent for Protection of its Recombinant Production System for Optimized Biosynthesis of Psilocybin

January 18, 2022

—

Core One Labs Special Investor Webcast Rescheduled to Friday, January 21, 2022

January 15, 2022

—

Core One Labs to Host Special Investor Webcast on Tuesday, January 18, 2022

conferences

January 8, 2022

—

Core One Labs Now Also Working to Biosynthesize DMT and Receives License

January 5, 2022

—

Core One Labs Applauds Health Canada’s Amendments to Special Access Program, Allowing Physicians to Request Patient Access to Psychedelic Treatments

December 23, 2021

—

Core One Labs Acquires New Path Laboratories

acquisition

CLABD has 10 recent news articles. Key topics include conferences, acquisition, clinical trial. View all CLABD news →

SEC Filings

View All

No SEC filings available for CLABD.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months